Renal Cancer - Results from #2240

Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience. January 15, 2021

Update on First-Line Combination Treatment Approaches in Metastatic Clear-Cell Renal Cell Carcinoma. January 15, 2021

Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma. January 15, 2021

Nomogram Predicting Survival to Assist Decision-Making of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma. January 14, 2021

Long Non-Coding RNA LINC02747 Promotes the Proliferation of Clear Cell Renal Cell Carcinoma by Inhibiting miR-608 and Activating TFE3. January 14, 2021

Cytoreductive stereotactic body radiotherapy (SBRT) and combination SBRT with immune checkpoint inhibitors (ICIs) in metastatic renal cell carcinoma. January 14, 2021

[Renal cell carcinoma of the kidney transplant: The French guidelines from CTAFU]. January 13, 2021

[Renal cell carcinoma in candidates for renal transplantation and recipients of a kidney transplant: The French guidelines from CTAFU]. January 13, 2021

Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival. January 13, 2021

Circ_101341 Deteriorates the Progression of Clear Cell Renal Cell Carcinoma Through the miR- 411/EGLN3 Axis. January 12, 2021

Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: a prospective cohort study. January 12, 2021

Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports. January 11, 2021

Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial. January 11, 2021

Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature. January 11, 2021

Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma. January 8, 2021

New Baseline Renal Function after Radical or Partial Nephrectomy: A Simple and Accurate Predictive Model. January 8, 2021

Dysregulation of Long Non-coding RNAs and mRNAs in Plasma of Clear Cell Renal Cell Carcinoma Patients Using Microarray and Bioinformatic Analysis. January 8, 2021

Outcomes of Active Surveillance for Young Patients with Small Renal Masses: Prospective Data from the DISSRM Registry. January 7, 2021

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma. January 7, 2021

MicroRNAs MiR-15a and MiR-26a cooperatively regulate O-GlcNAc-transferase to control proliferation in clear cell renal cell carcinoma. January 7, 2021

Page 113 of 456